XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Collaboration, Development and Supply Agreements - Additional Information (Detail) - USD ($)
 1 Months Ended 3 Months Ended
May 03, 2021
Sep. 30, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Oct. 31, 2021
Jan. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Account Receivable     $ 2,968,000   $ 15,600,000    
Revenue recognized     113,992,000 $ 83,335,000      
Accrued liabilities     16,108,000   49,796,000    
Other Revenues              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized     39,456 200,000      
CEPI Partners [Member] | Reservation Agreement              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Increase in interest free unsecured forgiveable loan maximum borrowing capacity $ 77,400,000            
Interest free unsecured forgiveable loan Maximum borrowing capacity $ 176,400,000            
Clover | Supply Agreement              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Deferred revenue     184,100,000   191,100,000    
Revenue recognized     22,300,000        
Accounts Receivable Net Current     6,900,000   2,100,000    
Contract asset balance     70,900,000   62,500,000    
Medigen | Supply Agreement              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized     6,900,000        
Accounts Receivable Net Current     2,400,000        
Valneva SE              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Advance payment from customer           $ 55,400,000  
Consideration Allocated To The Remaining Performance Obligation     55,400,000        
Deferred revenue     55,400,000        
Valneva SE | Supply Agreement              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Deferred revenue     55,400,000   55,400,000    
Revenue recognized     0 $ 64,900,000      
Biological E. Limited | Supply Agreement              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Deferred revenue     73,200,000   103,300,000    
Revenue recognized     67,300,000        
Accounts Receivable Net Current     104,300,000   96,100,000    
U.S. Department of Defense              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized     1,600,000        
Proceeds from grant   $ 22,000,000.0          
CEPI Member              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Interest- free unsecured forgivable loan             $ 99,000,000.0
Advance payment from customer     175,100,000        
Long-term deferred revenue         5,400,000    
Account Receivable     0   14,600,000    
Deferred revenue     400,000        
Accrued liabilities     $ 107,400,000   $ 128,800,000